Raymond James Financial Services Advisors, Inc. Intercept Pharmaceuticals, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$9.99 - $18.71 $780,069 - $1.46 Million	-78,085 Reduced 40.18%	116,267 $2.16 Million
Q2 2023 Jul 25, 2023	BUY	$9.17 - $19.29 $256,539 - $539,657	27,976 Added 16.81%	194,352 $2.15 Million
Q1 2023 Apr 14, 2023	SELL	$12.53 - $21.71 $43,867 - $76,006	-3,501 Reduced 2.06%	166,376 $2.23 Million
Q4 2022 Feb 08, 2023	SELL	$11.61 - $16.11 $78,971 - $109,580	-6,802 Reduced 3.85%	169,877 $2.1 Million
Q3 2022 Oct 25, 2022	BUY	$12.21 - $19.7 $288,290 - $465,136	23,611 Added 15.43%	176,679 $2.47 Million
Q2 2022 Aug 12, 2022	BUY	$11.23 - $19.59 $26,446 - $46,134	2,355 Added 1.56%	153,068 $2.11 Million
Q1 2022 May 11, 2022	SELL	$13.37 - $17.79 $161,402 - $214,760	-12,072 Reduced 7.42%	150,713 $2.45 Million
Q4 2021 Feb 08, 2022	BUY	$14.28 - $19.53 $163,848 - $224,087	11,474 Added 7.58%	162,785 $2.65 Million
Q3 2021 Nov 02, 2021	BUY	$12.99 - $20.47 $923,550 - $1.46 Million	71,097 Added 88.63%	151,311 $2.25 Million
Q2 2021 Aug 11, 2021	BUY	$15.46 - $24.5 $129,833 - $205,751	8,398 Added 11.69%	80,214 $1.6 Million
Q1 2021 May 14, 2021	BUY	$19.33 - $37.75 $519,841 - $1.02 Million	26,893 Added 59.86%	71,816 $1.66 Million
Q4 2020 Feb 12, 2021	SELL	$24.48 - $42.47 $197,651 - $342,902	-8,074 Reduced 15.23%	44,923 $1.11 Million
Q3 2020 Nov 04, 2020	SELL	$39.09 - $53.44 $721,132 - $985,861	-18,448 Reduced 25.82%	52,997 $2.2 Million
Q2 2020 Jul 17, 2020	BUY	$46.7 - $92.04 $795,301 - $1.57 Million	17,030 Added 31.3%	71,445 $3.42 Million
Q1 2020 Apr 21, 2020	BUY	$48.35 - $118.68 $2.47 Million - $6.06 Million	51,101 Added 1541.97%	54,415 $3.43 Million
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $186,018 - $402,456	-3,243 Reduced 49.46%	3,314 $411,000
Q3 2019 Nov 07, 2019	BUY	$58.69 - $80.46 $209,816 - $287,644	3,575 Added 119.89%	6,557 $435,000
Q2 2019 Aug 06, 2019	SELL	$77.77 - $120.68 $23,408 - $36,324	-301 Reduced 9.17%	2,982 $237,000
Q1 2019 May 06, 2019	BUY	$91.83 - $120.68 $301,477 - $396,192	3,283 New	3,283 $367,000
Q4 2018 Feb 11, 2019	SELL	$85.79 - $126.46 $473,303 - $697,679	-5,517 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $488,199 - $703,693	5,517 New	5,517 $697,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account